: Some of these effects are likely to be executed by genes which act as downstream mediators of p53 (Smith et al., 1994). Recently a link between p53 and cell cycle arrest was provided by the cloning of the cycin kinase inhibitor WAFI/CIPI, also called CDKN1 or p210l (El-Deiry et al., 1993; Harper et al., 1993) . WAFl/CIPl transcription is directly induced by p53 in response to DNA damage. It blocks the GI-S transition by inhibiting the activity of multiple cyclin-cyclin dependent kinase complexes (Xiong et al., 1993; Di Leonardo et al., 1994; El-Deiry et al., 1994 (von Deinling et al., 1992; Rubio et al., 1993; Louis, 1994) . In order to evaluate the hypothesis that WAF1/ CIPI mutations interrupt the p53-mediated pathway in brain tumours with wild-type p53, we performed single-strand conformational polymorphism (SSCP) analysis of both the WAFl/CIPl gene and the p53 gene in 158 human brain tumours. In addition we assessed these tumours for allelic loss in the WAFl/CLPl region on chromosomal arm 6p.
The p53 tumour-suppressor gene is frequently mutated in human brain tumours (Louis, 1994) . Wild-type p53 plays a major role in the cellular response to DNA damage, either by inducing a GI arrest and subsequent DNA repair or by inducing apoptosis (Lane, 1993) : Some of these effects are likely to be executed by genes which act as downstream mediators of p53 (Smith et al., 1994) . Recently a link between p53 and cell cycle arrest was provided by the cloning of the cycin kinase inhibitor WAFI/CIPI, also called CDKN1 or p210l (El-Deiry et al., 1993; Harper et al., 1993) . WAFl/CIPl transcription is directly induced by p53 in response to DNA damage. It blocks the GI-S transition by inhibiting the activity of multiple cyclin-cyclin dependent kinase complexes (Xiong et al., 1993; Di Leonardo et al., 1994; El-Deiry et al., 1994) . Further, the WAFI/CIPI gene product, p21, exerts a growth-suppressing effect if expressed under the control of a heterologous promoter (El-Deiry et al., 1993) .
This induction by p53 and its function as a negative regulator of the cell cycle make WAF1ICIPl an attractive candidate for a tumour-suppressor gene. Alterations of WAFl/CIPl function could constitute an alternative mechanism to p53 inactivation. Thus WAFI/CIPI mutations may contribute to the development of those tumours who have retained wild-type p53 alleles. Several studies have demonstrated a high incidence of p53 mutations in human gliomas, but have also documented that many gliomas express wildtype p53 (von Deinling et al., 1992; Rubio et al., 1993; Louis, 1994 al., 1993) . The specimens were examined microscopically before phenolic DNA extraction (Sambrook et al., 1989 We report on a large series of brain tumours examined for mutations in the WAFI/CIPI gene. No somatic mutations were found in 158 patients with brain tumours. Since we have only screened 87% of the coding sequence of the gene, we cannot exclude mutations in other regions, but an extensive study of the entire coding region of WAFI/CIPi in non-cerebral tumours also failed to detect mutations (Shiohara et al., 1994) . In addition, allelic loss of the WAFI/CIPI region of chromosomal arm 6p was extremely rare. We therefore conclude that WAFI/CIPI mutations are probably not involved in the formation of human brain tumours.
While no somatic mutations were detected in our study, we found a surprising number of different non-conservative polymorphisms. The most frequent polymorphism Al/A2 has been described in previous reports Shiohara et al., 1994) . In our series the frequencies for Al/A2 were 0.91/0.09 resulting in 15.8% heterozygotes. This Ser/ Arg polymorphism in codon 31 has been reported with a similar incidence Shiohara et al., 1994) .
We detected five additional polymorphisms (B-F) in the region of codons 14-64. All polymorphisms result in alterations of the amino acid sequence (see Table I ). Two other studies have failed to detect any of the variants except for the common Al/A2 polymorphism Shiohara et al., 1994) . AM of these polymorphisms reside in an area of greater than 90% homology at the protein level with the murine homologue, which is thought to encode a DNAbinding zinc-finger domain (El-Deiry et al., 1993; . This observation raises the possibility that these polymorphisms encode functionally distinct proteins, but transfection studies have shown no difference in the tumoursuppressor abilities of the serine and arginine alleles (Al/A2) in a lung cancer cell lne 
